The company

Biomedcode has been established by distinguished researchers in the field of immunological diseases, who have generated and characterized humanized models for these diseases. We have long experience in autoimmune and inflammatory disease models, and have provided our expertise and consultancy to a number of pharmaceutical companies for over 10 years.  Most importantly, a number of therapeutics that are on the market now for treating inflammatory disease have been previously tested on Biomedcode’s arthritis models.

While focusing primarily on providing services, our scientists are also actively engaged in generating novel humanized disease models to meet the needs of the pharmaceutical industry in autoimmune and inflammatory diseases.

For that purpose BioMedCode is also developing platforms for integrated drug evaluation including gene expression profiling.

The Scientific Management Team View Brief Bios of the Team